⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QURE News
uniQure N.V.
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
prnewswire.com
QURE
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
accessnewswire.com
QURE
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against uniQure N.V. – QURE
accessnewswire.com
QURE
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
globenewswire.com
QURE
Pomerantz LLP Informs Shareholders of Class Action Against uniQure N.V. – QURE
accessnewswire.com
QURE
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
QURE
Pomerantz LLP Informs Shareholders of Securities Class Action Filing Against uniQure N.V. – QURE
accessnewswire.com
QURE
Pomerantz LLP Notifies Investors of Class Action Against uniQure N.V. – QURE
accessnewswire.com
QURE
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
prnewswire.com
QURE
QURE INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of uniQure N.V. Investors
accessnewswire.com
QURE